Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Income per Common Share

Income per Common Share

6 Months Ended

May. 31, 2015

Earnings Per Share [Abstract]

Income per Common Share

Note 2 – Income per Common Share

The following table sets forth the calculation of basic and diluted net income per common share:


	Three Months Ended				Six Months Ended
	May 31, 2015		May 31, 2014		May 31, 2015		May 31, 2014
Numerator:
Net Income	$	210,032	$	215,773	$	496,202	$	612,885

Denominator:
Weighted-average shares outstanding-basic		9,809,127		10,250,471		9,816,762		10,467,914
Dilutive common shares issuable upon exercise of stock options		233,477		156,136		232,553		127,676

Weighted-average shares-diluted		10,042,604		10,406,607		10,049,315		10,595,590

Net income per common share:
Basic	$	0.02	$	0.02	$	0.05	$	0.06

Diluted	$	0.02	$	0.02	$	0.05	$	0.06

For the three and six months ended May 31, 2015, the Company excluded the effect of 271,000 and 271,000, respectively, outstanding options from the computation of diluted earnings per share, as the effect of potentially dilutive shares from the outstanding stock options would be anti-dilutive.

For the three and six months ended May 31, 2014, the Company excluded the effect of 296,001 and 419,334, respectively, outstanding options from the computation of diluted earnings per share, as the effect of potentially dilutive shares from the outstanding stock options would be anti-dilutive.